LHC Group had dropped close to 3.5% by market close on Thursday after a report suggested that the Federal Trade Commission is reviewing its pending deal with UnitedHealth Group again, this time due to a potential vertical harm theory, Home Health Care News reports.
Broadly, vertical harm theory concerns generally are tied to market competition concerns. Other factors could include misusing sensitive customer information, forestalling or eliminating entry, increasing opportunities to collude, or evading taxation or regulations.
The FTC’s information gathering has almost reached its conclusion, according to reports from Seeking Alpha, which cited traders and a Capitol Forum report. Read more.
